Curtana Pharmaceuticals Granted FDA Orphan Drug Designation

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas Abstract: Member company, Curtana Pharmaceuticals, announced that the FDA has granted orphan drug status to CT-179, the company’s lead Olig2 inhibitor. CT-179 is...
Contract Research Partnership Announced

Contract Research Partnership Announced

ABI has entered into a contract research agreement with Austin-based startup, Macromoltek, to test the viability of new computational antibody design algorithms experimentally. Macromoltek has an automated antibody design platform for difficult infectious diseases and...